<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01820481</url>
  </required_header>
  <id_info>
    <org_study_id>WIN-901X-P2</org_study_id>
    <nct_id>NCT01820481</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of WIN-901X in Asthma</brief_title>
  <official_title>Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase 2 : Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of WIN-901X in Asthma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Whanin Pharmaceutical Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Whanin Pharmaceutical Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is designed to evaluate the efficacy, dose-response and safety of
      WIN-901X in Asthma patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Double blinded, Randomized, Placebo Controlled, Multi-center, Phase 2 : Exploratory Clinical
      Study to Evaluate the Efficacy, Dose-response and Safety of WIN-901X in Asthma Patients
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the change of FEV1% to the baseline after the medication</measure>
    <time_frame>Baseline, week 12</time_frame>
    <description>FEV1: Forced Expiratory Volume In One Second</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the change of ACQ to the baseline after the medication</measure>
    <time_frame>Baseline, week 12</time_frame>
    <description>ACQ: Asthma Control Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of the date, where no rescue drug was used, during the trial</measure>
    <time_frame>Baseline, week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of symptom free days during the trial</measure>
    <time_frame>Baseline, week 12</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">209</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Treatment 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>WIN-901X dose level 1</intervention_name>
    <description>100mg Bid, PO, 12weeks</description>
    <arm_group_label>Treatment 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>WIN-901X dose level 2</intervention_name>
    <description>200mg Bid, PO, 12weeks</description>
    <arm_group_label>Treatment 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>WIN-901X dose level 3</intervention_name>
    <description>300mg Bid, PO, 12weeks</description>
    <arm_group_label>Treatment 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Bid, PO, 12weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Greater than or equal to 20 and less than 80 years of age

          -  Have physician diagnosed asthma with irreversible airway obstruction at least 6 months
             prior to the screening

          -  FEV1 between 60% and 85% before inhaling fast-acting bronchodilator at screening

          -  No history of smoking at least one year prior to the screening

          -  Having voluntarily signed an informed consent

        Exclusion Criteria:

          -  Have visited emergency room due to the worsening asthma symptoms, within 4 weeks
             before the screening

          -  Have been hospitalized due to an acute worsening of asthma within 3 months before the
             screening

          -  Have a history of laryngitis, pyrexia, sinusitis, otitis media, respiratory tract
             infection, and infectious rhinitis within 4 weeks prior to the screening

          -  Have malignant tumor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Park Hae Sim, M.D., Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Yes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ajou University Medical Center</name>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2013</study_first_submitted>
  <study_first_submitted_qc>March 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2013</study_first_posted>
  <last_update_submitted>December 5, 2013</last_update_submitted>
  <last_update_submitted_qc>December 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Bronchial Diseases</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <keyword>Lung Diseases, Obstructive</keyword>
  <keyword>Lung Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

